Department of Cardio-Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy.
Interventional Cardiology Unit, A. O. Ordine Mauriziano Umberto I, Turin, Italy.
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
The aim of this study was to compare, in a large all-comer registry, the long-term clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery (ULMCA) stenosis.
Limited data are available regarding clinical outcomes following DES implantation at the different ULMCA sites.
Patients with ULMCA stenosis treated by PCI with DES were analyzed in this multinational registry.
A total of 1,612 patients were included: 482 were treated for ostial/mid-shaft lesions versus 1,130 for distal bifurcation lesions. At a median follow-up period of 1,250 (interquartile range: 987 to 1,564) days, PCI for distal bifurcation lesions was associated with a higher incidence of major adverse cardiac events (propensity-score adjusted hazard ratio [HR]: 1.48, 95% confidence interval [CI]: 1.16 to 1.89; p = 0.001), largely because of the higher target vessel revascularization rate observed in this group as compared to the ostial/mid-shaft lesions group (propensity-score adjusted HR: 1.68, 95% CI: 1.19 to 2.38; p = 0.003). These results were sustained following propensity-score matched analysis. With regard to all-cause death and the composite endpoint of all-cause death and myocardial infarction, propensity-score adjusted analysis suggested a trend toward higher rates of these in the distal ULMCA PCI group, although this was not observed in the propensity-score matched analysis.
This study demonstrates that PCI for ostial/mid-shaft lesions is associated with better clinical outcomes than are distal bifurcation lesions in ULMCA, largely because there is a lower need for repeat revascularization in ostial/mid-shaft lesions.
本研究旨在比较经皮冠状动脉介入治疗(PCI)中药物洗脱支架(DES)治疗无保护左主干冠状动脉(ULMCA)狭窄的开口/中段病变与远端分叉病变的长期临床结果。
关于 DES 植入不同 ULMCA 部位的临床结果的数据有限。
本多国注册研究分析了接受 PCI 联合 DES 治疗的 ULMCA 狭窄患者。
共纳入 1612 例患者:482 例治疗开口/中段病变,1130 例治疗远端分叉病变。在中位数为 1250 天(四分位距:987 至 1564)的随访期间,远端分叉病变 PCI 的主要不良心脏事件发生率较高(倾向评分调整后的风险比 [HR]:1.48,95%置信区间 [CI]:1.16 至 1.89;p=0.001),这主要是由于与开口/中段病变组相比,该组的靶血管血运重建率更高(倾向评分调整后的 HR:1.68,95%CI:1.19 至 2.38;p=0.003)。这些结果在倾向评分匹配分析中得到了维持。在全因死亡和全因死亡和心肌梗死复合终点方面,倾向评分调整分析表明远端 ULMCA PCI 组的这些终点发生率较高,但在倾向评分匹配分析中并未观察到。
本研究表明,与远端分叉病变相比,ULMCA 开口/中段病变的 PCI 与更好的临床结果相关,这主要是因为开口/中段病变的再次血运重建需求较低。